CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada.
CRAFT
Canada
decentralized clinical trials
remote trial access
remote trial framework
remote trial management
trial cluster
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
30 09 2021
30 09 2021
Historique:
received:
13
08
2021
revised:
15
09
2021
accepted:
24
09
2021
entrez:
22
10
2021
pubmed:
23
10
2021
medline:
28
10
2021
Statut:
epublish
Résumé
Canada's vast geography, and centralized delivery of cancer care and clinical trials create barriers for trial participation for patients in remote and rural settings. The development and implementation of a framework that enables safe and regulatory compliant trial participation through local healthcare providers would benefit Canadian patients, clinicians, trial sponsors and the health care system. To address this issue, representatives of Canada's cancer clinical trial community met to identify key challenges and develop recommendations for remote patient participation in trials. A structured literature review identified remote/rural trial delivery models. A panel of expert stakeholders reviewed the models and participated in a workshop to assess health system readiness, identify needed processes, tools and mechanisms, and develop recommendations for a Canadian framework for decentralized clinical trial conduct. The Canadian Remote Access Framework for clinical Trials (CRAFT) represents a risk-based approach used by site investigators to delegate responsibilities for a given trial to satellite health centres within a hub-and-spoke "trial cluster". The Framework includes specific recommendations to ensure research experience, capacity, regulatory compliance and patient safety. Canada's cancer care and telemedicine systems can be leveraged to enable broader access to clinical trials for patients who are geographically remote from cancer centres. CRAFT's risk-based framework is based on other successful models of remote trial patient management and is in the pilot implementation phase in Canada.
Identifiants
pubmed: 34677247
pii: curroncol28050329
doi: 10.3390/curroncol28050329
pmc: PMC8534531
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3857-3865Références
J Oncol Pract. 2016 Apr;12(4):e350-8
pubmed: 27026649
Clin Trials. 2010 Aug;7(4):312-21
pubmed: 20595245
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12587
pubmed: 27726212
Curr Oncol Rep. 2017 Aug;19(8):52
pubmed: 28664469
J Natl Cancer Inst. 2007 Mar 21;99(6):420-2
pubmed: 17374826
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
Am Soc Clin Oncol Educ Book. 2016;35:185-98
pubmed: 27249699
J Natl Cancer Inst. 2019 Mar 1;111(3):245-255
pubmed: 30856272
Pediatr Blood Cancer. 2018 Apr;65(4):
pubmed: 29271602